Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04705116Recruiting

COVID-19 Vaccines International Pregnancy Exposure Registry

Role: lead

NCT05013632Recruiting

COVID-19 International Drug Pregnancy Registry

Role: lead

NCT05352256Terminated

Pregistry International Pregnancy Exposure Registry (PIPER)

Role: lead

NCT04366986Completed

International Registry of Coronavirus (COVID-19) Exposure in Pregnancy

Role: lead

NCT04385238Completed

Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic

Role: lead

NCT04694664Completed

COVID-19 Vaccine Confidence Among Pregnant Women and Mothers

Role: lead

All 6 trials loaded